Busmeon, Julie N.
HRN: 23-98-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
METRONIDAZOLE 500MG (TAB)
11/05/2023
11/11/2023
PO
500mg
Q8
AGE
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes